谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Dinutuximab Beta Plus Conventional Chemotherapy for Relapsed/refractory High-Risk Neuroblastoma: A Single-Center Experience.

Nur Olgun,Emre Cecen,Dilek Ince,Deniz Kizmazoglu,Birsen Baysal,Ayse Onal,Ozhan Ozdogan,Handan Guleryuz,Riza Cetingoz,Ayse Demiral,Mustafa Olguner,Ahmet Celik,Serra Kamer,Erdener Ozer,Zekiye Altun,Safiye Aktas

Frontiers in Oncology（2022）

引用 1|浏览17
暂无评分
关键词
neuroblastoma,relapsed,refractory,dinutuximab beta,anti-GD2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要